Abstract PO3-04-12: SUMIT-BC: Phase 2 Randomized Study of Fulvestrant with or Without the Cyclin-Dependent Kinase 7 Inhibitor (cdk7i) Samuraciclib in Advanced Hormone Receptor Positive (HR+) Breast Cancer after CDK4/6iGlen Clack,Sercan Aksoy,Meritxell Bellet Ezquerra,Begoña Bermejo,Cagatay Arslan,Maria Castro-Henriques,İrfan Çiçin,Mahmut Gümüş, Carmen Hinojo-González,Nuri Karadurmuş, Denisse Lee Cervantes, R. Lozano Mejorada,Emmanuel de la Mora Jimenez,Fernando Moreno,Sònia Pernas,Timothy Pluard, Carlos Zuloaga Fernandez del Valle,O. Yazıcı,Stuart McIntoshCancer Research（2024）引用 0|浏览4AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
